{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T19:15:57Z","timestamp":1792696557167,"version":"4.5.0"},"reference-count":128,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008402","name":"Chengdu University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["030040018"],"award-info":[{"award-number":["030040018"]}],"id":[{"id":"10.13039\/501100008402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ijbiomac.2023.125515","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T21:07:26Z","timestamp":1687381646000},"page":"125515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":61,"special_numbering":"C","title":["Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review"],"prefix":"10.1016","volume":"245","author":[{"given":"Yang","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaiwen","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2023.125515_bb0005","doi-asserted-by":"crossref","first-page":"1174223","DOI":"10.3389\/fimmu.2023.1174223","article-title":"Global transmission of monkeypox virus-a potential threat under the COVID-19 pandemic","volume":"14","author":"Wang","year":"2023","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125515_bb0010","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.jiph.2023.02.003","article-title":"Monkeypox (mpox) virus: classification, origin, transmission, genome organization, antiviral drugs, and molecular diagnosis","volume":"16","author":"Karagoz","year":"2023","journal-title":"J. Infect. Public Health"},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0015","article-title":"A call for a novel and next-generation vaccine against monkeypox disease","volume":"84","author":"Bhattacharya","year":"2022","journal-title":"Ann. Med. Surg. (Lond.)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125515_bb0020","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/viro.2002.1446","article-title":"Analysis of the monkeypox virus genome","volume":"297","author":"Shchelkunov","year":"2002","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125515_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28036","article-title":"Genomic annotation and molecular evolution of monkeypox virus outbreak in 2022","volume":"95","author":"Wang","year":"2023","journal-title":"J. Med. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125515_bb0030","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0014-5793(01)03144-1","article-title":"Human monkeypox and smallpox viruses: genomic comparison","volume":"509","author":"Shchelkunov","year":"2001","journal-title":"FEBS Lett."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125515_bb0035","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28322","article-title":"Inverted repeats in the monkeypox virus genome are hot spots for mutation","volume":"95","author":"Dobrovoln\u00e1","year":"2023","journal-title":"J. Med. Virol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125515_bb0040","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/s41591-022-01907-y","article-title":"Phylogenomic characterization and signs of microevolution in the 2022 multi-country outbreak of monkeypox virus","volume":"28","author":"Isidro","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0045","series-title":"Fields Virology Lippincott Raven","article-title":"Poxviridae: the viruses and their replication","author":"Moss","year":"1996"},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0050","first-page":"27(18)","article-title":"Kinetic and structural aspects of glycosaminoglycan-monkeypox virus protein A29 interactions using surface plasmon resonance","author":"Shi","year":"2022","journal-title":"Molecules"},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125515_bb0055","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1056\/NEJMoa032299","article-title":"The detection of monkeypox in humans in the Western hemisphere","volume":"350","author":"Reed","year":"2004","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125515_bb0060","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3201\/eid2002.130118","article-title":"Genomic variability of monkeypox virus among humans, Democratic Republic of the Congo","volume":"20","author":"Kugelman","year":"2014","journal-title":"Emerg. Infect. Dis."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0065","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.celrep.2013.06.028","article-title":"Vaccinia virus entry is followed by core activation and proteasome-mediated release of the immunomodulatory effector VH1 from lateral bodies","volume":"4","author":"Schmidt","year":"2013","journal-title":"Cell Rep."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125515_bb0070","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1128\/JVI.75.7.3185-3196.2001","article-title":"Vaccinia virus blocks gamma interferon signal transduction: viral VH1 phosphatase reverses Stat1 activation","volume":"75","author":"Najarro","year":"2001","journal-title":"J. Virol."},{"issue":"51","key":"10.1016\/j.ijbiomac.2023.125515_bb0075","doi-asserted-by":"crossref","first-page":"18572","DOI":"10.1073\/pnas.0509239102","article-title":"Poxvirus multiprotein entry\u2013fusion complex","volume":"102","author":"Senkevich","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0080","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcdb.2016.07.015","article-title":"Membrane fusion during poxvirus entry","volume":"60","author":"Moss","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0085","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1128\/JVI.80.1.51-61.2006","article-title":"Entry of vaccinia virus and cell-cell fusion require a highly conserved cysteine-rich membrane protein encoded by the A16L gene","volume":"80","author":"Ojeda","year":"2006","journal-title":"J. Virol."},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.125515_bb0090","doi-asserted-by":"crossref","first-page":"9458","DOI":"10.1128\/JVI.79.15.9458-9469.2005","article-title":"Vaccinia virus A21 virion membrane protein is required for cell entry and fusion","volume":"79","author":"Townsley","year":"2005","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125515_bb0095","doi-asserted-by":"crossref","first-page":"2348","DOI":"10.1128\/JVI.78.5.2348-2356.2004","article-title":"Vaccinia virus A28L gene encodes an essential protein component of the virion membrane with intramolecular disulfide bonds formed by the viral cytoplasmic redox pathway","volume":"78","author":"Senkevich","year":"2004","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125515_bb0100","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1128\/JVI.72.2.1577-1585.1998","article-title":"A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate","volume":"72","author":"Chung","year":"1998","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125515_bb0105","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1128\/JVI.74.7.3353-3365.2000","article-title":"Vaccinia virus envelope H3L protein binds to cell surface heparan sulfate and is important for intracellular mature virion morphogenesis and virus infection in vitro and in vivo","volume":"74","author":"Lin","year":"2000","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125515_bb0110","doi-asserted-by":"crossref","first-page":"3772","DOI":"10.1128\/jvi.62.10.3772-3778.1988","article-title":"Vaccinia virus gene D8 encodes a virion transmembrane protein","volume":"62","author":"Niles","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0115","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1128\/JVI.02302-06","article-title":"Vaccinia virus 4c (A26L) protein on intracellular mature virus binds to the extracellular cellular matrix laminin","volume":"81","author":"Chiu","year":"2006","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.ijbiomac.2023.125515_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081963","article-title":"Glycosaminoglycans and glycosaminoglycan mimetics in cancer and inflammation","volume":"20","author":"Morla","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125515_bb0125","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.coviro.2011.11.007","article-title":"Poxvirus host cell entry","volume":"2","author":"Schmidt","year":"2012","journal-title":"Curr. Opin. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125515_bb0130","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.chom.2013.12.008","article-title":"siRNA screen of early poxvirus genes identifies the AAA+ ATPase D5 as the virus genome-uncoating factor","volume":"15","author":"Kilcher","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125515_bb0135","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1091\/mbc.12.7.2031","article-title":"Vaccinia virus DNA replication occurs in endoplasmic reticulum-enclosed cytoplasmic mini-nuclei","volume":"12","author":"Tolonen","year":"2001","journal-title":"Mol. Biol. Cell"},{"issue":"6627","key":"10.1016\/j.ijbiomac.2023.125515_bb0140","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1126\/science.ade6360","article-title":"Structure of monkeypox virus DNA polymerase holoenzyme","volume":"379","author":"Peng","year":"2023","journal-title":"Science"},{"issue":"16","key":"10.1016\/j.ijbiomac.2023.125515_bb0145","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1016\/S0021-9258(18)36019-8","article-title":"Purification and properties of the deoxyribonucleic acid polymerase induced by vaccinia virus","volume":"254","author":"Challberg","year":"1979","journal-title":"J. Biol. Chem."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125515_bb0150","doi-asserted-by":"crossref","DOI":"10.3390\/v12070707","article-title":"Conserved oligomeric Golgi (COG) complex proteins facilitate orthopoxvirus entry, fusion and spread","volume":"12","author":"Realegeno","year":"2020","journal-title":"Viruses"},{"issue":"Pt 12","key":"10.1016\/j.ijbiomac.2023.125515_bb0155","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1099\/0022-1317-83-12-2915","article-title":"The formation and function of extracellular enveloped vaccinia virus","volume":"83","author":"Smith","year":"2002","journal-title":"J. Gen. Virol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125515_bb0160","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1083\/jcb.200104124","article-title":"Vaccinia virus utilizes microtubules for movement to the cell surface","volume":"154","author":"Hollinshead","year":"2001","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125515_bb0165","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1517\/13543784.17.4.555","article-title":"ACAM2000: a newly licensed cell culture-based live vaccinia smallpox vaccine","volume":"17","author":"Greenberg","year":"2008","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0170","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/DDDT.S3687","article-title":"ACAM2000: the new smallpox vaccine for United States strategic National Stockpile","volume":"4","author":"Nalca","year":"2010","journal-title":"Drug Des. Dev. Ther."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125515_bb0175","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.27931","article-title":"Epidemiological trends and clinical features of the ongoing monkeypox epidemic: a preliminary pooled data analysis and literature review","volume":"95","author":"Bragazzi","year":"2023","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0180","article-title":"Nordic announces US Food and Drug Administration approval of JYNNEOS (smallpox and monkeypox vaccine, live, nonreplicating) for prevention of smallpox and monkeypox disease in adults","volume":"70(2):I-I","author":"Bavarian","year":"2020","journal-title":"Clin. Infect. Dis."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125515_bb0185","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-022-02090-w","article-title":"Low levels of monkeypox virus-neutralizing antibodies after MVA-BN vaccination in healthy individuals","volume":"29","author":"Zaeck","year":"2023","journal-title":"Nat. Med."},{"issue":"20","key":"10.1016\/j.ijbiomac.2023.125515_bb0190","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1001\/jama.2022.18320","article-title":"Human Monkeypox virus infection in the immediate period after receiving modified vaccinia Ankara vaccine","volume":"328","author":"Hazra","year":"2022","journal-title":"Jama"},{"issue":"50","key":"10.1016\/j.ijbiomac.2023.125515_bb0195","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.50.2200882","article-title":"Outcomes of post-exposure vaccination by modified vaccinia Ankara to prevent mpox (formerly monkeypox): a retrospective observational study in Lyon, France, June to August 2022","volume":"27","author":"Merad","year":"2022","journal-title":"Euro Surveill."},{"issue":"48","key":"10.1016\/j.ijbiomac.2023.125515_bb0200","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2022.27.48.2200894","article-title":"Severe mpox (formerly monkeypox) disease in five patients after recent vaccination with MVA-BN vaccine, Belgium, July to October 2022","volume":"27","author":"Berens-Riha","year":"2022","journal-title":"Euro Surveill."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0205","series-title":"medRxiv","article-title":"Effectiveness of one dose of MVA-BN smallpox vaccine against monkeypox in England using the case-coverage method","author":"Bertran","year":"2022"},{"issue":"47\u201348","key":"10.1016\/j.ijbiomac.2023.125515_bb0210","doi-asserted-by":"crossref","first-page":"7009","DOI":"10.1016\/j.vaccine.2006.03.087","article-title":"LC16m8: an attenuated smallpox vaccine","volume":"24","author":"Kenner","year":"2006","journal-title":"Vaccine"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125515_bb0215","doi-asserted-by":"crossref","first-page":"4152","DOI":"10.1073\/pnas.0406671102","article-title":"Genetically stable and fully effective smallpox vaccine strain constructed from highly attenuated vaccinia LC16m8","volume":"102","author":"Kidokoro","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125515_bb0220","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1093\/infdis\/jir527","article-title":"Safety and immunogenicity of LC16m8, an attenuated smallpox vaccine in vaccinia-naive adults","volume":"204","author":"Kennedy","year":"2011","journal-title":"J. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125515_bb0225","doi-asserted-by":"crossref","first-page":"408","DOI":"10.7883\/yoken.JJID.2016.417","article-title":"A single vaccination of nonhuman primates with highly attenuated smallpox vaccine, LC16m8, provides long-term protection against monkeypox","volume":"70","author":"Iizuka","year":"2017","journal-title":"Jpn. J. Infect. Dis."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125515_bb0230","doi-asserted-by":"crossref","first-page":"6667","DOI":"10.1073\/pnas.062163799","article-title":"Complete pathway for protein disulfide bond formation encoded by poxviruses","volume":"99","author":"Senkevich","year":"2002","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125515_bb0235","doi-asserted-by":"crossref","first-page":"5988","DOI":"10.1128\/jvi.64.12.5988-5996.1990","article-title":"Use of a cell-free system to identify the vaccinia virus L1R gene product as the major late myristylated virion protein M25","volume":"64","author":"Franke","year":"1990","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125515_bb0240","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.virol.2008.12.019","article-title":"Vaccinia virus L1 binds to cell surfaces and blocks virus entry independently of glycosaminoglycans","volume":"385","author":"Foo","year":"2009","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125515_bb0245","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/viro.1995.1378","article-title":"A myristylated membrane protein encoded by the vaccinia virus L1R open reading frame is the target of potent neutralizing monoclonal antibodies","volume":"211","author":"Wolffe","year":"1995","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125515_bb0250","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.virol.2007.06.042","article-title":"Structural basis for the binding of the neutralizing antibody, 7D11, to the poxvirus L1 protein","volume":"368","author":"Su","year":"2007","journal-title":"Virology"},{"issue":"15","key":"10.1016\/j.ijbiomac.2023.125515_bb0255","doi-asserted-by":"crossref","first-page":"8050","DOI":"10.1128\/JVI.00836-12","article-title":"Structural and biochemical characterization of the vaccinia virus envelope protein D8 and its recognition by the antibody LA5","volume":"86","author":"Matho","year":"2012","journal-title":"J. Virol."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125515_bb0260","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.vaccine.2008.10.031","article-title":"Vaccinia virus proteins activate human dendritic cells to induce T cell responses in vitro","volume":"27","author":"Agrawal","year":"2009","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0265","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1128\/JVI.79.3.1623-1634.2005","article-title":"Vaccinia virus penetration requires cholesterol and results in specific viral envelope proteins associated with lipid rafts","volume":"79","author":"Chung","year":"2005","journal-title":"J. Virol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125515_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/v14112531","article-title":"A vaccine strategy based on the identification of an annular ganglioside binding motif in monkeypox virus protein E8L","volume":"14","author":"Fantini","year":"2022","journal-title":"Viruses"},{"issue":"16","key":"10.1016\/j.ijbiomac.2023.125515_bb0275","doi-asserted-by":"crossref","first-page":"7508","DOI":"10.1128\/JVI.74.16.7508-7517.2000","article-title":"Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail","volume":"74","author":"da Fonseca","year":"2000","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125515_bb0280","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2249.2007.03401.x","article-title":"Long-term T cell memory to human leucocyte antigen-A2 supertype epitopes in humans vaccinated against smallpox","volume":"149","author":"Ostrout","year":"2007","journal-title":"Clin. Exp. Immunol."},{"issue":"6","key":"10.1016\/j.ijbiomac.2023.125515_bb0285","doi-asserted-by":"crossref","DOI":"10.3390\/v14061224","article-title":"New p35 (H3L) epitope involved in vaccinia virus neutralization and its deimmunization","volume":"14","author":"Khlusevich","year":"2022","journal-title":"Viruses"},{"issue":"18","key":"10.1016\/j.ijbiomac.2023.125515_bb0290","doi-asserted-by":"crossref","first-page":"11724","DOI":"10.1128\/JVI.79.18.11724-11733.2005","article-title":"Vaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice","volume":"79","author":"Davies","year":"2005","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125515_bb0295","doi-asserted-by":"crossref","first-page":"8374","DOI":"10.1128\/JVI.72.10.8374-8379.1998","article-title":"Cell surface proteoglycans are necessary for A27L protein-mediated cell fusion: identification of the N-terminal region of A27L protein as the glycosaminoglycan-binding domain","volume":"72","author":"Hsiao","year":"1998","journal-title":"J. Virol."},{"issue":"Pt 1","key":"10.1016\/j.ijbiomac.2023.125515_bb0300","first-page":"47","article-title":"The vaccinia virus A27L protein is needed for the microtubule-dependent transport of intracellular mature virus particles","volume":"81","author":"Sanderson","year":"2000","journal-title":"J. Gen. Virol."},{"issue":"20","key":"10.1016\/j.ijbiomac.2023.125515_bb0305","doi-asserted-by":"crossref","first-page":"10010","DOI":"10.1128\/JVI.00601-06","article-title":"Human T-cell responses to vaccinia virus envelope proteins","volume":"80","author":"Tang","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0310","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.virol.2014.06.039","article-title":"A highly specific monoclonal antibody against monkeypox virus detects the heparin binding domain of A27","volume":"464-465","author":"Hughes","year":"2014","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0315","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1021\/pr070432+","article-title":"Comparative proteomics of human monkeypox and vaccinia intracellular mature and extracellular enveloped virions","volume":"7","author":"Manes","year":"2008","journal-title":"J. Proteome Res."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125515_bb0320","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1128\/JVI.02247-09","article-title":"The structure of the poxvirus A33 protein reveals a dimer of unique C-type lectin-like domains","volume":"84","author":"Su","year":"2010","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125515_bb0325","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02155-19","article-title":"Vaccinia virus glycoproteins A33, A34, and B5 form a complex for efficient endoplasmic reticulum to trans-Golgi network transport","volume":"94","author":"Monticelli","year":"2020","journal-title":"J. Virol."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125515_bb0330","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1128\/JVI.78.5.2486-2493.2004","article-title":"Vaccinia virus A36R membrane protein provides a direct link between intracellular enveloped virions and the microtubule motor kinesin","volume":"78","author":"Ward","year":"2004","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125515_bb0335","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1016\/j.molimm.2008.12.016","article-title":"In vitro human CD4+ T cell response to the vaccinia protective antigens B5R and A33R","volume":"46","author":"Sirven","year":"2009","journal-title":"Mol. Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125515_bb0340","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005148","article-title":"Structural and functional characterization of anti-A33 antibodies reveal a potent cross-species orthopoxviruses neutralizer","volume":"11","author":"Matho","year":"2015","journal-title":"PLoS Pathog."},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125515_bb0345","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.virol.2008.04.003","article-title":"Heterogeneity in the A33 protein impacts the cross-protective efficacy of a candidate smallpox DNA vaccine","volume":"377","author":"Golden","year":"2008","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125515_bb0350","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/0042-6822(92)90535-W","article-title":"A constitutively expressed vaccinia gene encodes a 42-kDa glycoprotein related to complement control factors that forms part of the extracellular virus envelope","volume":"188","author":"Engelstad","year":"1992","journal-title":"Virology"},{"issue":"17","key":"10.1016\/j.ijbiomac.2023.125515_bb0355","doi-asserted-by":"crossref","first-page":"8763","DOI":"10.1128\/JVI.00598-06","article-title":"Interaction between vaccinia virus extracellular virus envelope A33 and B5 glycoproteins","volume":"80","author":"Perdiguero","year":"2006","journal-title":"J. Virol."},{"issue":"Pt 9","key":"10.1016\/j.ijbiomac.2023.125515_bb0360","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1099\/vir.0.043943-0","article-title":"Protein B5 is required on extracellular enveloped vaccinia virus for repulsion of superinfecting virions","volume":"93","author":"Doceul","year":"2012","journal-title":"J. Gen. Virol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125515_bb0365","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1038\/nm1457","article-title":"Quantification of antibody responses against multiple antigens of the two infectious forms of vaccinia virus provides a benchmark for smallpox vaccination","volume":"12","author":"P\u00fctz","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0370","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.antiviral.2017.05.002","article-title":"Development of an animal model of progressive vaccinia in nu\/nu mice and the use of bioluminescence imaging for assessment of the efficacy of monoclonal antibodies against vaccinial B5 and L1 proteins","volume":"144","author":"Zaitseva","year":"2017","journal-title":"Antivir. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0375","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1128\/JVI.02152-12","article-title":"Unusual features of vaccinia virus extracellular virion form neutralization resistance revealed in human antibody responses to the smallpox vaccine","volume":"87","author":"Benhnia","year":"2013","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0380","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1586\/erv.10.5","article-title":"Complement-bound human antibodies to vaccinia virus B5 antigen protect mice from virus challenge","volume":"9","author":"Paran","year":"2010","journal-title":"Expert Rev. Vaccines."},{"issue":"23","key":"10.1016\/j.ijbiomac.2023.125515_bb0385","doi-asserted-by":"crossref","first-page":"12355","DOI":"10.1128\/JVI.01593-09","article-title":"Heavily isotype-dependent protective activities of human antibodies against vaccinia virus extracellular virion antigen B5","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0390","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1128\/JVI.01797-08","article-title":"Vaccinia virus extracellular enveloped virion neutralization in vitro and protection in vivo depend on complement","volume":"83","author":"Benhnia","year":"2009","journal-title":"J. Virol."},{"issue":"21","key":"10.1016\/j.ijbiomac.2023.125515_bb0395","doi-asserted-by":"crossref","first-page":"13454","DOI":"10.1128\/JVI.79.21.13454-13462.2005","article-title":"Combinations of polyclonal or monoclonal antibodies to proteins of the outer membranes of the two infectious forms of vaccinia virus protect mice against a lethal respiratory challenge","volume":"79","author":"Lustig","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0400","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1186\/1743-422X-8-441","article-title":"Polyclonal antibody cocktails generated using DNA vaccine technology protect in murine models of orthopoxvirus disease","volume":"8","author":"Golden","year":"2011","journal-title":"Virol. J."},{"issue":"12","key":"10.1016\/j.ijbiomac.2023.125515_bb0405","doi-asserted-by":"crossref","first-page":"6023","DOI":"10.4049\/jimmunol.1202523","article-title":"CD4+ T cells provide intermolecular help to generate robust antibody responses in vaccinia virus-vaccinated humans","volume":"190","author":"Yin","year":"2013","journal-title":"J. Immunol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125515_bb0410","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1128\/JVI.01854-07","article-title":"Vaccination of BALB\/c mice with Escherichia coli-expressed vaccinia virus proteins A27L, B5R, and D8L protects mice from lethal vaccinia virus challenge","volume":"82","author":"Berhanu","year":"2008","journal-title":"J. Virol."},{"issue":"7","key":"10.1016\/j.ijbiomac.2023.125515_bb0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042353","article-title":"Side-by-side comparison of gene-based smallpox vaccine with MVA in nonhuman primates","volume":"7","author":"Golden","year":"2012","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0420","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01504-21","article-title":"A nucleic acid-based orthopoxvirus vaccine targeting the vaccinia virus L1, A27, B5, and A33 proteins protects rabbits against lethal Rabbitpox virus aerosol challenge","volume":"96","author":"Mucker","year":"2022","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125515_bb0425","doi-asserted-by":"crossref","first-page":"4433","DOI":"10.1128\/JVI.78.9.4433-4443.2004","article-title":"Smallpox DNA vaccine protects nonhuman primates against lethal monkeypox","volume":"78","author":"Hooper","year":"2004","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125515_bb0430","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.4049\/jimmunol.177.4.2552","article-title":"Subunit recombinant vaccine protects against monkeypox","volume":"177","author":"Heraud","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0435","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.633776","article-title":"A guide to nucleic acid vaccines in the prevention and treatment of infectious diseases and cancers: from basic principles to current applications","volume":"9","author":"Qin","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0440","series-title":"medRxiv","article-title":"Antibodies to SARS-CoV-2 are associated with protection against reinfection","author":"Lumley","year":"2020"},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125515_bb0445","doi-asserted-by":"crossref","DOI":"10.1172\/JCI157707","article-title":"A multitope SARS-CoV-2 vaccine provides long-lasting B cell and T cell immunity against Delta and omicron variants","volume":"132","author":"Wang","year":"2022","journal-title":"J. Clin. Invest."},{"issue":"6152","key":"10.1016\/j.ijbiomac.2023.125515_bb0450","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1126\/science.1244040","article-title":"Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects","volume":"341","author":"Li","year":"2013","journal-title":"Science."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0455","doi-asserted-by":"crossref","first-page":"1035924","DOI":"10.3389\/fimmu.2022.1035924","article-title":"Immuno-informatics profiling of monkeypox virus cell surface binding protein for designing a next generation multi-valent peptide-based vaccine","volume":"13","author":"Yousaf","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0460","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2022.102481","article-title":"Designing, characterization, and immune stimulation of a novel multi-epitopic peptide-based potential vaccine candidate against monkeypox virus through screening its whole genome encoded proteins: an immunoinformatics approach","volume":"50","author":"Bhattacharya","year":"2022","journal-title":"Travel Med. Infect. Dis."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125515_bb0465","doi-asserted-by":"crossref","DOI":"10.3390\/v14112374","article-title":"Immunoinformatics-aided design of a peptide based multiepitope vaccine targeting glycoproteins and membrane proteins against monkeypox virus","volume":"14","author":"Akhtar","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0470","doi-asserted-by":"crossref","first-page":"1091941","DOI":"10.3389\/fimmu.2023.1091941","article-title":"Immunoinformatics design of multivalent epitope vaccine against monkeypox virus and its variants using membrane-bound, enveloped, and extracellular proteins as targets","volume":"14","author":"Waqas","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0475","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109728","article-title":"Developing a multiepitope vaccine for the prevention of SARS-CoV-2 and monkeypox virus co-infection: a reverse vaccinology analysis","volume":"115","author":"Jiang","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"19","key":"10.1016\/j.ijbiomac.2023.125515_bb0480","doi-asserted-by":"crossref","first-page":"10230","DOI":"10.1128\/JVI.78.19.10230-10237.2004","article-title":"Protective immunity to vaccinia virus induced by vaccination with multiple recombinant outer membrane proteins of intracellular and extracellular virions","volume":"78","author":"Fogg","year":"2004","journal-title":"J. Virol."},{"issue":"4","key":"10.1016\/j.ijbiomac.2023.125515_bb0485","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2215\/CJN.0000000000000108","article-title":"Effectiveness of three doses of mRNA COVID-19 vaccines in the hemodialysis population during the omicron period","volume":"18","author":"Wing","year":"2023","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0490","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.actbio.2018.08.033","article-title":"Engineering DNA vaccines against infectious diseases","volume":"80","author":"Lee","year":"2018","journal-title":"Acta Biomater."},{"issue":"16","key":"10.1016\/j.ijbiomac.2023.125515_bb0495","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1056\/NEJMc2036242","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"384","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.ijbiomac.2023.125515_bb0500","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0505","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.xphs.2020.12.006","article-title":"Addressing the cold reality of mRNA vaccine stability","volume":"110","author":"Crommelin","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0510","article-title":"The use of viral vectors in vaccine development","volume":"7(1):75","author":"Travieso","year":"2022","journal-title":"NPJ Vaccines"},{"issue":"31","key":"10.1016\/j.ijbiomac.2023.125515_bb0515","doi-asserted-by":"crossref","first-page":"4997","DOI":"10.1016\/j.vaccine.2010.05.023","article-title":"Single-shot immunization with recombinant adenovirus encoding vaccinia virus glycoprotein A27L is protective against a virulent respiratory poxvirus infection","volume":"28","author":"Rudraraju","year":"2010","journal-title":"Vaccine."},{"issue":"48","key":"10.1016\/j.ijbiomac.2023.125515_bb0520","doi-asserted-by":"crossref","first-page":"6108","DOI":"10.1016\/j.vaccine.2008.09.007","article-title":"Comparison of multiple vaccine vectors in a single heterologous prime-boost trial","volume":"26","author":"Barefoot","year":"2008","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0525","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1172\/JCI81083","article-title":"Beyond antigens and adjuvants: formulating future vaccines","volume":"126","author":"Moyer","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0530","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583077","article-title":"Emerging concepts and technologies in vaccine development","volume":"11","author":"Brisse","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125515_bb0535","doi-asserted-by":"crossref","first-page":"16982","DOI":"10.1021\/acsnano.1c04996","article-title":"Lipid nanoparticlesfrom liposomes to mRNA vaccine delivery, a landscape of research diversity and advancement","volume":"15","author":"Tenchov","year":"2021","journal-title":"ACS Nano"},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0540","article-title":"Polyvalent mRNA vaccination elicited potent immune response to monkeypox virus surface antigens","volume":"1-4","author":"Fang","year":"2023","journal-title":"Cell Res."},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0545","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.coviro.2021.03.008","article-title":"Future considerations for the mRNA-lipid nanoparticle vaccine platform","volume":"48","author":"Igy\u00e1rt\u00f3","year":"2021","journal-title":"Curr. Opin. Virol."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125515_bb0550","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/pharmaceutics9020012","article-title":"Liposomal formulations in clinical use: an updated review","volume":"9","author":"Bulbake","year":"2017","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0555","article-title":"Protein-based antigen presentation platforms for nanoparticle vaccines","volume":"6(1):70","author":"Nguyen","year":"2021","journal-title":"NPJ Vaccines"},{"issue":"11","key":"10.1016\/j.ijbiomac.2023.125515_bb0560","article-title":"Development of a SARS-CoV-2 vaccine candidate using plant-based manufacturing and a tobacco mosaic virus-like nano-particle","volume":"9","author":"Royal","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125515_bb0565","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1021\/acsnano.0c08379","article-title":"Rapid development of SARS-CoV-2 spike protein receptor-binding domain self-assembled nanoparticle vaccine candidates","volume":"15","author":"Kang","year":"2021","journal-title":"ACS Nano"},{"issue":"1","key":"10.1016\/j.ijbiomac.2023.125515_bb0570","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1038\/s41467-022-30222-w","article-title":"Quadrivalent mosaic HexaPro-bearing nanoparticle vaccine protects against infection of SARS-CoV-2 variants","volume":"13","author":"Kang","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0575","doi-asserted-by":"crossref","first-page":"3703","DOI":"10.1021\/acsnano.0c00962","article-title":"Cell-penetrating nanoparticles activate the inflammasome to enhance antibody production by targeting microtubule-associated protein 1-light chain 3 for degradation","volume":"14","author":"Zhu","year":"2020","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.ijbiomac.2023.125515_bb0580","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1039\/D1TB02408F","article-title":"Nano dimensions\/adjuvants in COVID-19 vaccines","volume":"10","author":"Alphand\u00e9ry","year":"2022","journal-title":"J. Mater. Chem. B"},{"issue":"17","key":"10.1016\/j.ijbiomac.2023.125515_bb0585","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.201700574","article-title":"Carbon nanomaterials in biological studies and biomedicine","volume":"6","author":"Teradal","year":"2017","journal-title":"Adv. Healthc. Mater."},{"issue":"6348","key":"10.1016\/j.ijbiomac.2023.125515_bb0590","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/354056a0","article-title":"Helical microtubules of graphitic carbon","volume":"354","author":"Iijima","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0595","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.2147\/IJN.S299448","article-title":"Carbon nanotubes: smart drug\/gene delivery carriers","volume":"16","author":"Zare","year":"2021","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0600","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.fsi.2019.11.035","article-title":"Carbon nanotube-based DNA vaccine against koi herpesvirus given by intramuscular injection","volume":"98","author":"Hu","year":"2020","journal-title":"Fish Shellfish Immunol."},{"issue":"9","key":"10.1016\/j.ijbiomac.2023.125515_bb0605","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nnano.2010.153","article-title":"Repeated administrations of carbon nanotubes in male mice cause reversible testis damage without affecting fertility","volume":"5","author":"Bai","year":"2010","journal-title":"Nat. Nanotechnol."},{"issue":"40","key":"10.1016\/j.ijbiomac.2023.125515_bb0610","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202102528","article-title":"Large-sized graphene oxide nanosheets increase DC-T-cell synaptic contact and the efficacy of DC vaccines against SARS-CoV-2","volume":"33","author":"Zhou","year":"2021","journal-title":"Adv. Mater."},{"issue":"20","key":"10.1016\/j.ijbiomac.2023.125515_bb0615","doi-asserted-by":"crossref","DOI":"10.3390\/ma14205978","article-title":"Biomedical applications of carbon nanomaterials: fullerenes, quantum dots, nanotubes, nanofibers, and graphene","volume":"14","author":"Gaur","year":"2021","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0620","series-title":"Handbook of Computational Chemistry","first-page":"1","article-title":"Structures and stability of fullerenes, metallofullerenes, and their derivatives","author":"Popov","year":"2016"},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0625","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.drudis.2019.01.013","article-title":"Fullerene-based delivery systems","volume":"24","author":"Kazemzadeh","year":"2019","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.ijbiomac.2023.125515_bb0630","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jare.2019.01.004","article-title":"Shedding light on gene therapy: carbon dots for the minimally invasive image-guided delivery of plasmids and noncoding RNAs - a review","volume":"18","author":"Mohammadinejad","year":"2019","journal-title":"J. Adv. Res."},{"issue":"3","key":"10.1016\/j.ijbiomac.2023.125515_bb0635","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/s41591-023-02229-3","article-title":"Real-world effectiveness of a single dose of mpox vaccine in males","volume":"29","author":"Sagy","year":"2023","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.ijbiomac.2023.125515_bb0640","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1128\/jvi.56.2.482-488.1985","article-title":"Isolation and characterization of neutralizing monoclonal antibodies to vaccinia virus","volume":"56","author":"Rodriguez","year":"1985","journal-title":"J. Virol."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023024091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813023024091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,27]],"date-time":"2024-09-27T19:06:34Z","timestamp":1727463994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813023024091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":128,"alternative-id":["S0141813023024091"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125515","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunogenic proteins and potential delivery platforms for mpox virus vaccine development: A rapid review","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2023.125515","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"125515"}}